Hemant Surgical Industries Ltd.
HSIL.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.52B
Close$
Share Statistics
| Market cap | $9.52 Billion |
|---|---|
| Enterprise Value | $9.58 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $15.39 |
| Beta | 1.11 |
| Outstanding Shares | 12,433,000 |
Return
| Return on Equity | 19.06% |
|---|---|
| Return on Assets | 9.56% |
| Return on Invested Capital | 25.99% |
Valuation & Multiples
| P/E Ratio | 43.25 |
|---|---|
| PEG | 26.69 |
| Price to Sales | 2.45 |
| Price to Book Ratio | 6.05 |
| Enterprise Value to Revenue | 2.83 |
| Enterprise Value to EBIT | 26.11 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hemant Surgical Industries Ltd.
109 employees
CEO: Hanskumar Shamji Shah Hemant Surgical Industries Ltd. functions as a pharmaceutical enterprise, focusing on the import, production, and distribution of both surgical equipment and pharmaceutical items. Hanskumar Shamji Shah established the firm in 1985, and its primary operations are based in Mumbai, India.